finnCap Research Company Notes - 5 June 2020

Jun 05, 2020 / News

Avacta (AVTG.L) : Corp

Life Sciences

Fundraise of £48m – pursuing multiple opportunities

Key data

 

 

Share price (p)

 

150.0

Target price (p)

 

U/R

Market cap (£m)

 

312.0

Enterprise value (£m)

 

301.5

 

Avacta has conditionally raised £45m net to (i) accelerate the expansion of its therapeutics pipeline, given recent pre-clinical data for both its pre|CISION and TMAC drug conjugate platforms, and (ii) provide the necessary working capital to fund the development and deployment of a COVID-19 antigen test in the summer of 2020 as well as scale its broader diagnostics business more rapidly. These funds will also generate first-in-man data (safety and tolerability) for the Affimer platform, which will significantly de-risk the platform in the eyes of potential pharma partners, accelerate its partnership model and substantially increase future deal values. We leave our target price under review, although using a SOTP analysis, it is easy to generate a valuation that is substantially in excess of the current market capitalisation.

 

Mark Brewer

mbrewer@finncap.com

020 7220 0556

 

 

M.P. Evans (MPE) : Corp

Industrial Technology

AGM update: excellent start to the year

Key data

 

 

Share price (p)

 

575.0

Target price (p)

 

1 000.0

Market cap (£m)

 

313.2

Enterprise value (£m)

 

340.9

 

MPE has released an AGM trading statement covering the first five months of the financial year (to end May 2020). The statement highlights a very strong start to the year with +16% y-o-y growth in FFB harvest and +35% y-o-y growth in CPO equivalent volumes. Production YTD is consistent with, or slightly ahead of, our full-year forecasts, and we expect the usual seasonal weight to H2. Significantly, the COVID pandemic has had no impact on operations, cash generation remains strong and investment continues as planned. We are making no changes to our forecasts or price target.

 

Raymond Greaves

020 7220 0553

rgreaves@finncap.com

 

 

 

Somero Enterprises (SOM) : Corp

Industrial Technology

Trading update

Key data

 

 

Share price (p)

 

205.0

Target price (p)

 

U/R

Market cap (£m)

 

115.5

Enterprise value (£m)

 

96.6

 

The group’s trading update has identified that COVID-19 has reduced sales by around 25% from that expected at the start of the year, although with a flexible operating model and cost and cash-saving actions taken, the group remains profitable and cash generative. Indeed, the balance sheet remains robust with $24m in cash, a similar level to March. The outlook for customer demand remains uncertain, while investment in NPD has been maintained in order to accelerate sales once the recovery occurs. Our forecasts remain under review, while prospects for the long-term remain strong.

 

David Buxton

020 7220 0542

dbuxton@finncap.com

 

 

 

Revolution Bars Group (RBG) : Corp

Consumer & Other

Proposed equity fundraising and move to AIM

Key data

 

 

Share price (p)

 

35.0

Target price (p)

 

U/R

Market cap (£m)

 

17.5

Enterprise value (£m)

 

39.5

 

New management has put in place a strategy which the February interim results revealed was returning the group to growth with very encouraging LFL statistics and attractive returns on refurbished outlets. In March, however, in response to COVID-19 and following UK Government guidelines, all venues had to be closed. Management initiatives have materially reduced the cash burn while the group is unable to trade, and the group’s lender has been very supportive in significantly increasing the borrowing facility. Management is now proposing an equity issue, the rationale for which is to strengthen the leverage ratio to create a more appropriate capital structure moving forward, to allow an immediate return to the estate refurbishment programme and to be able to potentially take advantage of strategic opportunities as they arise as the sector emerges from the COVID-19 crisis.

 

Mark Paddon

mpaddon@finncap.com

020 7220 0541